Site icon almostadoctor

Gonorrhoea

Introduction

Gonorrhoea is a sexually transmitted infection, caused by Nisseria Gonorrhoae (aka Gonococcus, GC, “the clap”) – a Gram-negative intracellular diplococcus. It only infects humans, and likes moist areas, typically infecting the genitourinary tracts, retum, pharynx and conjunctiva. It is particularly intolerant to a dry environment.
It is usually spread by person to person contact, but there are occasional reports of its spread via inanimate objects (fomites). Most commonly spread by sexual transmission, but also spread via vertical transmission from mother to baby. This can result in a conjunctivitis (ophthalmia neonatum), which if untreated can result in blindness, and is an ophthalmological emergency.
It is most commonly seen in men who have sex with men (MSM). In Australia, it is also often seen in heterosexual individuals from Aboriginal and Torres Strait Islander populations, and in those returning from overseas from high prevalence locations.
Previous infection does not provide immunity.

Epidemiology

Aetiology

High number of sexual partners
Non-practice of safe sex
Sharing sex toys
Associated with other STI’s

Neisseria gonorrhoeae. Note the intracellular Gram-negative diplococci, and pleomorphic extracellular Gram-negative organisms, which is diagnostic for Gonorrhoea – although the more recent NAAT PCR is now the recommended diagnostic test.

Clinical features

50% of women and 10% of men are asymptomatic
It has an incubation period of 2-14 days. Most people get symptoms about 2-5 days after infection.  
Symptoms consistent with Urethritis:

Gonorrhoea of the rectum – sometimes seen in MSM. Can vary from being symptom free, to causing a discharge of painful bloody pus from the rectum (proctitis)
Extra symptoms in women – inter-menstrual bleeding, pelvic pain (with an ascending infection)

Complications

Men – the infection can ascend the urinary tract, and cause epididymitis or prostatitis. These can be acute or chronic.

Women:

Diagnosis

Testing can either be performed by swab for culture, or swab for NAAT (nucleic acid amplification testing – I.e. PCR)

Smear testing – a swab from the urethra, cervix, throat or rectum can be used for diagnosis.

Nucleic acid amplification testing – (NAAT’s) this uses a urine sample, and is highly sensitive

Blood culture, and joint aspiration – should be performed if disseminated GC is suspected
Tests for other common STD’s should be performed in light of a positive diagnosis of GC – e.g. syphilis, chlamydia and trichomonas.

Recommended testing methods
Men

Women

Treatment

Should be given to anyone with a positive test for GC. It may also be given to anyone who has had close sexual contact with the patient, via contract tracing. It can usually be treated with a single dose of AB’s:

Agents – about 10% of GC is resistant to penicillin and ciprofloxacin, and about 40% is resistant to tetracyclines.

As a result of increasing resistance, dual therapy is now usually recommended, with azithromycin and ceftriaxone. Anogenital infection and conjunctivitis

Pharyngeal infection

As above, but the dose of azithromycin is doubled:

In areas where resistance is low you could consider the following (in Australia, this only applies to some remote locations or in cases of severe allergic reactions):

Complicated and disseminated cases will require longer courses of treatment. The patient should be followed up 72 hours after treatment to check efficacy.

Advice to patients
  • Advise no sexual contact for 7 days after treatment
  • Advise no sex with partners from the last 6 months until partners have been tested (and treated if required)
  • Advise about contact tracing
    • Trace partners for the last 6 months
    • Offer treatment to all sexual contacts
  • Provide written information factsheet
  • In Australia – notify the state or territory health department (notifiable disease)

Follow-up

Advised at one week and again at 3 months.

Follow-up at one week to ensure:

  • Compliance
  • Partner tracing has occurred, or offer support for this

Test of cure (TOC) is recommended for some groups (including for most cases in women):

  • Cervical infection
  • Pharyngeal infection

Perform repeat NAAT testing 2 weeks after finishing treatment if indicated

  • If TOC is positive – seek specialist advice
Re-infection is common. Some centres suggest re-testing all patients at 3 months to rule out re-infection.

Screening

  • Although not an official ‘screening’ program, the NHS promotes free chlamydia and gonorrhoea testing in the R U Clear campaign.
    • Eligible to under 25’s
    • Text (SMS) details to the service, and they send out a pack in the post
    • ‘Pee in the pot’ and send it back
    • Results sent out via SMS text messaging
  • Although urethral swab (men) and endocervical swab (women) is the best way of detecting chlamydia, the urine test is deemed accurate enough in an environment of such high prevalence of STD.
  • In Australia:
    • It is recommended to screen all sexually active people aged 15-29 annually for chlamydia (+/- gonorrhea)
    • There is no ‘official’ screening programme – instead it is recommended that health professionals (especially GPs) opportunistically offer screening to those aged 15-29 when they present for whatever reason

References

Read more about our sources

Related Articles

Exit mobile version